These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25973320)

  • 1. Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
    Zhu LC; Gao J; Hu ZH; Schwab CL; Zhuang HY; Tan MZ; Yan LM; Liu JJ; Zhang DY; Lin B
    Am J Cancer Res; 2015; 5(2):830-43. PubMed ID: 25973320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
    Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
    J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
    Gao J; Hu Z; Liu J; Liu D; Wang Y; Cai M; Zhang D; Tan M; Lin B
    Med Oncol; 2014 May; 31(5):920. PubMed ID: 24692145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer.
    Vallius T; Hynninen J; Auranen A; Matomäki J; Oksa S; Roering P; Grènman S
    Tumour Biol; 2017 Feb; 39(2):1010428317691189. PubMed ID: 28218038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.
    Aarenstrup Karlsen M; Høgdall C; Nedergaard L; Philipsen Prahm K; Schou Karlsen NM; Weng Ekmann-Gade A; Henrichsen Schnack T; Svenstrup Poulsen T; Jarle Christensen I; Høgdall E
    APMIS; 2016 Dec; 124(12):1038-1045. PubMed ID: 27859687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical expression of integrin alphav, beta5 and beta3 in ovarian epithelial carcinoma: correlation with drug resistance of chemotherapy].
    Guo HY; Han JS; Zhang LF; Wang LN; Geng L; Chen GA
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):750-3. PubMed ID: 15634501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and correlation of Lewis y antigen and integrins α5 and β1 in ovarian serous and mucinous carcinoma.
    Li Q; Liu S; Lin B; Yan L; Wang Y; Wang C; Zhang S
    Int J Gynecol Cancer; 2010 Dec; 20(9):1482-9. PubMed ID: 21119363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38 MAPK Pathway.
    Gao J; Zhu L; Zhuang H; Lin B
    Adv Ther; 2022 Jan; 39(1):360-378. PubMed ID: 34739698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.
    Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B
    Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
    Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.
    Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression and potential synergy of human epididymis protein 4 and Annexin A8 promote progression and predict poor prognosis in epithelial ovarian cancer.
    Zhu L; Gou R; Guo Q; Wang J; Liu Q; Lin B
    Am J Transl Res; 2020; 12(7):4017-4030. PubMed ID: 32774755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of Lewis y and integrin α5β1 correlate with chemotherapeutic drug resistance in epithelial ovarian carcinoma.
    Hu Z; Gao S; Gao J; Hou R; Liu C; Liu J; Li B; Liu D; Zhang S; Lin B
    Int J Mol Sci; 2012 Nov; 13(12):15588-600. PubMed ID: 23443083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
    Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
    PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased HE4 mRNA Expression Correlates with High Level Of eIF3a mRNA And Better Survival in Women with Epithelial Ovarian Cancer.
    Luo CH; Zhao M; Tang YX; Shahabi S; Fang KN; Chen Y; Tang Y; Chen XY; Wang J; Zhou HH
    J Cancer; 2018; 9(6):1088-1095. PubMed ID: 29581788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells.
    Zhuang H; Hu Z; Tan M; Zhu L; Liu J; Liu D; Yan L; Lin B
    Biochimie; 2014 Oct; 105():91-8. PubMed ID: 24998328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
    Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
    Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.
    Nassir M; Guan J; Luketina H; Siepmann T; Rohr I; Richter R; Castillo-Tong DC; Zeillinger R; Vergote I; Van Nieuwenhuysen E; Concin N; Marth C; Hall C; Mahner S; Woelber L; Sehouli J; Braicu EI
    Tumour Biol; 2016 Mar; 37(3):3009-16. PubMed ID: 26419591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.